Genetic knockdown of Klk8 has sex-specific multi-targeted therapeutic effects on Alzheimer's pathology in mice.
Arne HerringNirup K KurapatiSofia KrebsNils GrammonLuisa M ScholzGerrit VossMuhammad R MiahVanessa BudnyFabian MairingerKatharina HaaseSarah Teuber-HanselmannCelia DobersalskeSara SchrammKarl-Heinz JöckelYvonne MünsterKathy KeyvaniPublished in: Neuropathology and applied neurobiology (2021)
These results reinforce the potential of KLK8 as a therapeutic target in AD.